Literature DB >> 15336226

Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA.

Helen D Donoghue1, Mark Spigelman, Charles L Greenblatt, Galit Lev-Maor, Gila Kahila Bar-Gal, Carney Matheson, Kim Vernon, Andreas G Nerlich, Albert R Zink.   

Abstract

During the past 10 years palaeomicrobiology, a new scientific discipline, has developed. The study of ancient pathogens by direct detection of their DNA has answered several historical questions and shown changes to pathogens over time. However, ancient DNA (aDNA) continues to be controversial and great care is needed to provide valid data. Here we review the most successful application of the technology, which is the study of tuberculosis. This has provided direct support for the current theory of Mycobacterium tuberculosis evolution, and suggests areas of investigation for the interaction of M tuberculosis with its host.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15336226     DOI： 10.1016/S1473-3099(04)01133-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


  36 in total

1.  Comment. Pathogenic microbial ancient DNA: a problem or an opportunity?

Authors:  Helen D Donoghue; Mark Spigelman
Journal:  Proc Biol Sci       Date:  2006-03-22       Impact factor: 5.349

2.  Evaluating bacterial pathogen DNA preservation in museum osteological collections.

Authors:  Ian Barnes; Mark G Thomas
Journal:  Proc Biol Sci       Date:  2006-03-22       Impact factor: 5.349

3.  Wild-type MIC distributions must be considered to set clinically meaningful susceptibility testing breakpoints for all bacterial pathogens, including Mycobacterium tuberculosis.

Authors:  Kristian Angeby; Christian G Giske; Pontus Juréen; Thomas Schön; Jotam G Pasipanodya; Tawando Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2011-09       Impact factor: 5.191

4.  Time-dependent diaryl ether inhibitors of InhA: structure-activity relationship studies of enzyme inhibition, antibacterial activity, and in vivo efficacy.

Authors:  Pan Pan; Susan E Knudson; Gopal R Bommineni; Huei-Jiun Li; Cheng-Tsung Lai; Nina Liu; Miguel Garcia-Diaz; Carlos Simmerling; Sachindra S Patil; Richard A Slayden; Peter J Tonge
Journal:  ChemMedChem       Date:  2014-03-11       Impact factor: 3.466

5.  Effect of High Glucose on Human Alveolar Macrophage Phenotype and Phagocytosis of Mycobacteria.

Authors:  Jesse Vance; Andres Santos; Laura Sadofsky; Alyn Morice; Jorge Cervantes
Journal:  Lung       Date:  2018-11-24       Impact factor: 2.584

Review 6.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  The emergence of latent infection in the early evolution of Mycobacterium tuberculosis.

Authors:  Rebecca H Chisholm; Mark M Tanaka
Journal:  Proc Biol Sci       Date:  2016-05-25       Impact factor: 5.349

8.  Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis.

Authors:  I L Bergval; R N C P Vijzelaar; E R Dalla Costa; A R J Schuitema; L Oskam; A L Kritski; P R Klatser; R M Anthony
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

Review 9.  Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis.

Authors:  Noel H Smith; R Glyn Hewinson; Kristin Kremer; Roland Brosch; Stephen V Gordon
Journal:  Nat Rev Microbiol       Date:  2009-06-01       Impact factor: 60.633

10.  Molecular exploration of the first-century Tomb of the Shroud in Akeldama, Jerusalem.

Authors:  Carney D Matheson; Kim K Vernon; Arlene Lahti; Renee Fratpietro; Mark Spigelman; Shimon Gibson; Charles L Greenblatt; Helen D Donoghue; Boaz Zissu
Journal:  PLoS One       Date:  2009-12-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.